# Perrigo Company plc (PRGO) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Healthcare / Pharmaceuticals. Price $15.70, market value $2.2 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Perrigo Company plc reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 0.5×**. Each dollar of revenue is priced at 0.5×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 0.9×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Free-cash-flow yield: 5.5%** (5-yr avg 5.7%). Free cash flow equals 5.5% of the market value, in line with its five-year average of 5.7%. Above 5% is generally attractive.

## Profitability
- **Gross margin: 33.3%**. Perrigo Company plc keeps 33.3% of revenue after the direct cost of what it sells.
- **Operating margin: -37.7%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -33.5%**. The company reported a net loss over the last twelve months.
- **Return on equity: -48.6%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -18.8%**. Return on all capital, debt included, is -18.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -20.3%**. Each dollar of assets produces -20.3% of profit.

## Growth
- **Revenue growth (1 yr): -2.8%** (3-yr -1.5%/yr, 5-yr 0.8%/yr). Revenue fell 2.8% over the last year, against 0.8% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -723.2%**. Earnings per share fell 723.2%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): -11.7%/yr**. Free cash flow has compounded at -11.7% a year over three years.

## Financial health
- **Debt to equity: 1.24**. Debt is 1.24 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Current ratio: 2.76** (quick 2.76). Current assets cover the next year's liabilities 2.76 times.
- **Altman Z-score: 1.03**. A Z-score of 1.03 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 7.39%** ($1.16 per share, trailing). Perrigo Company plc yields 7.39%, high enough to check carefully: yields this high often precede a cut.
- **Dividend growth (5 yr): 3.9%/yr** (1-yr -1.5%). The dividend has grown 3.9% a year over five years.

## Analyst view
- **Analyst consensus: buy** (3 analysts). 3 analysts cover Perrigo Company plc; the consensus is buy, with an average price target of $18.00 (+15% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -20.3%** (YTD 18.7%, 3-mo 47.5%). The shares are down 20.3% over twelve months including dividends.
- **From 52-week high: -23.9%** (70.1% above the low). Trading 24% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 55**. An RSI of 55 is neutral.
- **Beta (1 yr): 0.99** (volatility 56%). Beta of 0.99 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=PRGO · Page: https://foliofundamentals.com/stocks/prgo

Not investment advice.